Pharmaceutical compositions comprising natriuretic peptides...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/22 (2006.01) A61K 38/04 (2006.01) A61K 38/55 (2006.01)

Patent

CA 2119019

2119019 9305809 PCTABS00021 Treatment or prevention of myointimal proliferation in atherosclerosis, restenosis induced by angioplasty or vascular reconstructive surgery, glomerulonephritis, glomerulosclerosis or other diseases involving vascular cell proliferation, with a natriuretic peptide or a neutral endopeptidase inhibitor such as N-[N-[(L)-[1-[(2,2-dimethyl-1,3-dioxolan-4-yl)methoxy]carbonyl]-2-phenylethyl_ ]-L-phenylalanyl]-.beta.-alanine and N-[2-mercaptomethyl-3-(2-methylphenyl)propionyl]-methionine, or with a neutral endopeptidase inhibitor in combination with a natriuretic peptide or an angiotensin converting enzyme inhibitor are disclosed.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Pharmaceutical compositions comprising natriuretic peptides... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical compositions comprising natriuretic peptides..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical compositions comprising natriuretic peptides... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1417309

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.